Masafumi Nakamura

Masafumi Nakamura

Auto-generated profile, based on publicly available information

Masafumi Nakamura

Department of Surgery and Oncology, Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009
Verified
Journal Article
Closed access
JWJunji Wada
Junji Wada
HSHiroyuki Suzuki
Hiroyuki Suzuki
RFRyouta Fuchino
Ryouta Fuchino
AYAkio Yamasaki
Akio Yamasaki
SNShuntaro Nagai
Shuntaro Nagai
MKMitsuo Katano
Mitsuo Katano

1 June 2010
Verified
Journal Article
Closed access
NCNobuhito Chikazawa
Nobuhito Chikazawa
HTHaruo Tanaka
Haruo Tanaka
TTTakehiko Tasaka
Takehiko Tasaka
MNMasafumi Nakamura
Masafumi Nakamura
MTMasao Tanaka
Masao Tanaka
MKMitsuo Katano
Mitsuo Katano

9 May 2013 in Oncology Reports
Verified
Journal Article
Open access
PDF file
HKHiroshi Kono
Hiroshi Kono
MNMasafumi Nakamura
Masafumi Nakamura
TOTakao Ohtsuka
Takao Ohtsuka
YNYosuke Nagayoshi
Yosuke Nagayoshi
YMYasuhisa Mori
Yasuhisa Mori
MTMasao Tanaka
Masao Tanaka
The prognosis of gallbladder cancer (GBC) remains poor despite recent advances in diagnostics and therapeutic strategies. Although the role of microRNAs (miRs) in GBC have not been well documented, miR-155 is known to be associated with inflammation-associated carcinogenesis in various types of cancers. The aim of this study was to investigate the clinical significance of miR-155 expression and the biological functions of miR-155 in GBC. The expression levels of miR-155 in surgically resected GBCs and gallbladders with pancreaticobiliary maljunction (PBM) were assessed by quantitative reverse transcription-polymerase chain reaction. The relationship between the expression levels of miR-155 and clinicopathological features of GBCs was analyzed. Human GBC cell lines were transfected with miR-155 inhibitors or mimics, and the effects on proliferation and invasion were assessed. miR-155 was significantly overexpressed in GBCs when compared with that in gallbladders with PBM (p=0.007) and normal gallbladders (p=0.04). The high expression level of miR-155 in GBCs was significantly associated with the presence of lymph node metastasis (p=0.01) and a poor prognosis (p=0.02). In vitro assays showed that aberrant expression of miR-155 significantly enhanced GBC cell proliferation and invasion. In conclusion, high miR-155 expression correlates with the aggressive behavior of GBCs, and miR-155 may become a prognostic marker and therapeutic target for GBC.


1 March 2009
Verified
Journal Article
Closed access
CKChizu Kameda
Chizu Kameda
HTHaruo Tanaka
Haruo Tanaka
AYAkio Yamasaki
Akio Yamasaki
MNMasafumi Nakamura
Masafumi Nakamura
KKKenichiro Koga
Kenichiro Koga
MKMitsuo Katano
Mitsuo Katano

1 March 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
YNYosuke Nagayoshi
Yosuke Nagayoshi
MNMasafumi Nakamura
Masafumi Nakamura
KMKazuhiro Matsuoka
Kazuhiro Matsuoka
TOTakao Ohtsuka
Takao Ohtsuka
YMYasuhisa Mori
Yasuhisa Mori
MTMasao Tanaka
Masao Tanaka